EUSA Pharma has acquired 2 companies of its own, including 2 in the last 5 years.
EUSA Pharma’s largest acquisition to date was in 2018, when it acquired SYLVANT for $115M. EUSA Pharma has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to EUSA Pharma’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 2